SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3q1o'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1AM6_A_HAEA555_1
(CARBONIC ANHYDRASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 7 HIS A  31
LEU A 120
THR A 117
THR A 116
 None
 0.79A 1am6A-3q1oA:
undetectable		 1am6A-3q1oA:
23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E7C_A_HLTA4007_1
(SERUM ALBUMIN)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 8 TYR A 128
LEU A  34
PHE A  38
LEU A  27
 None
 1.06A 1e7cA-3q1oA:
2.4		 1e7cA-3q1oA:
19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KIA_D_SAMD3293_1
(GLYCINE
N-METHYLTRANSFERASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 5 ILE A 191
ARG A  50
ASP A 229
ASN A 255
 None
DMA  A 500 (-3.1A)
None
None
 1.33A 1kiaD-3q1oA:
0.0		 1kiaD-3q1oA:
19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NBI_C_SAMC2293_1
(GLYCINE
N-METHYLTRANSFERASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 4 ILE A 191
ARG A  50
ASP A 229
ASN A 255
 None
DMA  A 500 (-3.1A)
None
None
 1.43A 1nbiC-3q1oA:
0.0		 1nbiC-3q1oA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NBI_D_SAMD3293_1
(GLYCINE
N-METHYLTRANSFERASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 4 ILE A 191
ARG A  50
ASP A 229
ASN A 255
 None
DMA  A 500 (-3.1A)
None
None
 1.45A 1nbiD-3q1oA:
0.0		 1nbiD-3q1oA:
21.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RQJ_A_RISA901_1
(GERANYLTRANSTRANSFER
ASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		11 / 11 SER A  88
LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 (-3.4A)
DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.40A 1rqjA-3q1oA:
35.1		 1rqjA-3q1oA:
34.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RQJ_B_RISB903_1
(GERANYLTRANSTRANSFER
ASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		11 / 11 SER A  88
LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 (-3.4A)
DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.39A 1rqjB-3q1oA:
35.1		 1rqjB-3q1oA:
34.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YHL_A_RISA1400_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 11 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.50A 1yhlA-3q1oA:
30.3		 1yhlA-3q1oA:
23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YQ7_A_RISA901_1
(FARNESYL
PYROPHOSPHATE
SYNTHETASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 11 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.48A 1yq7A-3q1oA:
30.9		 1yq7A-3q1oA:
27.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YV5_A_RISA901_1
(FARNESYL
PYROPHOSPHATE
SYNTHETASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.18A 1yv5A-3q1oA:
31.0		 1yv5A-3q1oA:
27.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YV5_A_RISA901_1
(FARNESYL
PYROPHOSPHATE
SYNTHETASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.47A 1yv5A-3q1oA:
31.0		 1yv5A-3q1oA:
27.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZW5_A_ZOLA901_1
(FARNESYL DIPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.51A 1zw5A-3q1oA:
31.3		 1zw5A-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZW5_A_ZOLA901_1
(FARNESYL DIPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 9 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.18A 1zw5A-3q1oA:
31.3		 1zw5A-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2E91_A_ZOLA901_1
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHETASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		8 / 9 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
 0.52A 2e91A-3q1oA:
20.7		 2e91A-3q1oA:
26.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2E91_B_ZOLB902_1
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHETASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		8 / 9 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
 0.69A 2e91B-3q1oA:
19.9		 2e91B-3q1oA:
26.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EZ7_A_DHIA301_0
(CARBONIC ANHYDRASE 2)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 6 HIS A 110
ASN A  99
THR A 108
PRO A 107
 None
 1.41A 2ez7A-3q1oA:
undetectable		 2ez7A-3q1oA:
24.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F89_F_210F9001_1
(FARNESYL DIPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		8 / 9 ASP A  92
ASP A  98
ARG A 103
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.40A 2f89F-3q1oA:
31.6		 2f89F-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F89_F_210F9001_1
(FARNESYL DIPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 9 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.18A 2f89F-3q1oA:
31.6		 2f89F-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F8C_F_ZOLF9001_1
(FARNESYL DIPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 11 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.17A 2f8cF-3q1oA:
31.4		 2f8cF-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F8C_F_ZOLF9001_1
(FARNESYL DIPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 11 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.48A 2f8cF-3q1oA:
31.4		 2f8cF-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F8Z_F_ZOLF5001_1
(FARNESYL DIPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.15A 2f8zF-3q1oA:
31.5		 2f8zF-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F8Z_F_ZOLF5001_1
(FARNESYL DIPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.51A 2f8zF-3q1oA:
31.5		 2f8zF-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F94_F_BFQF9001_1
(FARNESYL DIPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 12 LEU A  89
ASP A  92
ASP A  98
ARG A 103
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.48A 2f94F-3q1oA:
31.1		 2f94F-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F94_F_BFQF9001_1
(FARNESYL DIPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 12 LEU A  89
ASP A  92
ASP A  98
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.67A 2f94F-3q1oA:
31.1		 2f94F-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F9K_F_ZOLF9001_1
(FARNESYL DIPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.48A 2f9kF-3q1oA:
31.3		 2f9kF-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2O1O_A_RISA400_1
(PUTATIVE FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		8 / 9 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
 0.48A 2o1oA-3q1oA:
27.4		 2o1oA-3q1oA:
28.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2O1O_B_RISB400_1
(PUTATIVE FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		8 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
 0.46A 2o1oB-3q1oA:
28.1		 2o1oB-3q1oA:
28.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q58_A_ZOLA1_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		8 / 10 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 229
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
None
 0.54A 2q58A-3q1oA:
27.8		 2q58A-3q1oA:
28.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q58_A_ZOLA1_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		8 / 10 LEU A  89
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 229
 DMA  A 501 ( 4.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
None
 0.63A 2q58A-3q1oA:
27.8		 2q58A-3q1oA:
28.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q58_B_ZOLB2_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		7 / 9 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
 0.50A 2q58B-3q1oA:
27.3		 2q58B-3q1oA:
28.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QIS_A_RISA901_1
(FARNESYL
PYROPHOSPHATE
SYNTHETASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.21A 2qisA-3q1oA:
31.2		 2qisA-3q1oA:
27.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QIS_A_RISA901_1
(FARNESYL
PYROPHOSPHATE
SYNTHETASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.49A 2qisA-3q1oA:
31.2		 2qisA-3q1oA:
27.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EZ3_A_ZOLA397_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE, PUTATIVE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.47A 3ez3A-3q1oA:
31.0		 3ez3A-3q1oA:
26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EZ3_B_ZOLB397_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE, PUTATIVE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.45A 3ez3B-3q1oA:
30.3		 3ez3B-3q1oA:
26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EZ3_C_ZOLC397_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE, PUTATIVE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.48A 3ez3C-3q1oA:
30.9		 3ez3C-3q1oA:
26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EZ3_D_ZOLD397_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE, PUTATIVE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.45A 3ez3D-3q1oA:
29.9		 3ez3D-3q1oA:
26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IBA_A_ZOLA901_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 10 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.50A 3ibaA-3q1oA:
30.2		 3ibaA-3q1oA:
23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JZ0_B_CLYB900_1
(LINCOSAMIDE
NUCLEOTIDYLTRANSFERA
SE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 8 TYR A 128
GLU A 131
PHE A  39
ILE A 121
 None
 0.95A 3jz0B-3q1oA:
2.7		 3jz0B-3q1oA:
25.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LDW_A_ZOLA397_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.49A 3ldwA-3q1oA:
30.9		 3ldwA-3q1oA:
26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LDW_B_ZOLB397_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.47A 3ldwB-3q1oA:
30.2		 3ldwB-3q1oA:
26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LDW_C_ZOLC397_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.48A 3ldwC-3q1oA:
30.8		 3ldwC-3q1oA:
26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LDW_D_ZOLD397_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.46A 3ldwD-3q1oA:
29.9		 3ldwD-3q1oA:
26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N45_F_ZOLF354_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 11 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.20A 3n45F-3q1oA:
31.5		 3n45F-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N45_F_ZOLF354_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 11 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.47A 3n45F-3q1oA:
31.5		 3n45F-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N46_F_ZOLF354_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.50A 3n46F-3q1oA:
31.2		 3n46F-3q1oA:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TBG_C_RTZC1_1
(CYTOCHROME P450 2D6)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 12 LEU A  89
PHE A  39
GLY A  46
GLU A  82
PHE A  16
 DMA  A 501 ( 4.8A)
None
DMA  A 500 (-3.4A)
DMA  A 500 ( 4.6A)
None
 1.27A 3tbgC-3q1oA:
undetectable		 3tbgC-3q1oA:
20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HWK_B_SFYB806_0
(SEPIAPTERIN
REDUCTASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 11 LEU A 146
SER A  80
LEU A  79
MET A 197
ALA A 201
 None
 1.18A 4hwkB-3q1oA:
undetectable		 4hwkB-3q1oA:
25.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HWK_C_SFYC804_0
(SEPIAPTERIN
REDUCTASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 12 LEU A 146
SER A  80
LEU A  79
MET A 197
ALA A 201
 None
 1.19A 4hwkC-3q1oA:
undetectable		 4hwkC-3q1oA:
25.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HWK_C_SFYC804_0
(SEPIAPTERIN
REDUCTASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 12 LEU A 146
SER A  80
LEU A  79
PRO A  51
MET A 197
 None
 1.34A 4hwkC-3q1oA:
undetectable		 4hwkC-3q1oA:
25.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HWK_D_SFYD803_0
(SEPIAPTERIN
REDUCTASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 11 LEU A 146
SER A  80
LEU A  79
MET A 197
ALA A 201
 None
 1.14A 4hwkD-3q1oA:
undetectable		 4hwkD-3q1oA:
25.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HWK_D_SFYD803_0
(SEPIAPTERIN
REDUCTASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 11 LEU A 146
SER A  80
LEU A  79
PRO A  51
MET A 197
 None
 1.31A 4hwkD-3q1oA:
undetectable		 4hwkD-3q1oA:
25.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KFA_A_ZOLA404_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.51A 4kfaA-3q1oA:
31.0		 4kfaA-3q1oA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KPD_A_RISA405_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.44A 4kpdA-3q1oA:
31.4		 4kpdA-3q1oA:
27.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KPJ_A_210A901_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 9 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.27A 4kpjA-3q1oA:
31.0		 4kpjA-3q1oA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KPJ_A_210A901_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 LEU A  89
ASP A  92
ASP A  98
ARG A 103
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.51A 4kpjA-3q1oA:
31.0		 4kpjA-3q1oA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KQ5_A_ZOLA404_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.51A 4kq5A-3q1oA:
31.1		 4kq5A-3q1oA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KQS_A_RISA405_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.23A 4kqsA-3q1oA:
31.4		 4kqsA-3q1oA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KQS_A_RISA405_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.47A 4kqsA-3q1oA:
31.4		 4kqsA-3q1oA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N9U_A_RISA404_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.22A 4n9uA-3q1oA:
31.1		 4n9uA-3q1oA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N9U_A_RISA404_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.51A 4n9uA-3q1oA:
31.1		 4n9uA-3q1oA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NG6_A_RISA405_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 12 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.24A 4ng6A-3q1oA:
31.1		 4ng6A-3q1oA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NG6_A_RISA405_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 12 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.67A 4ng6A-3q1oA:
31.1		 4ng6A-3q1oA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKE_A_RISA404_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.22A 4nkeA-3q1oA:
31.0		 4nkeA-3q1oA:
27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKE_A_RISA404_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.59A 4nkeA-3q1oA:
31.0		 4nkeA-3q1oA:
27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKF_A_210A404_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 9 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.26A 4nkfA-3q1oA:
31.0		 4nkfA-3q1oA:
27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKF_A_210A404_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 LEU A  89
ASP A  92
ASP A  98
ARG A 103
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.51A 4nkfA-3q1oA:
31.0		 4nkfA-3q1oA:
27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NUA_A_RISA901_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.28A 4nuaA-3q1oA:
31.1		 4nuaA-3q1oA:
27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NUA_A_RISA901_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.64A 4nuaA-3q1oA:
31.1		 4nuaA-3q1oA:
27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ODO_A_FK5A205_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 LEU A 298
LEU A 291
LEU A 195
ILE A 191
PHE A  49
 None
 0.95A 4odoA-3q1oA:
undetectable		 4odoA-3q1oA:
16.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ODO_B_FK5B203_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 LEU A 298
LEU A 291
LEU A 195
ILE A 191
PHE A  49
 None
 0.98A 4odoB-3q1oA:
undetectable		 4odoB-3q1oA:
16.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ODO_C_FK5C204_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 LEU A 298
LEU A 291
LEU A 195
ILE A 191
PHE A  49
 None
 1.02A 4odoC-3q1oA:
undetectable		 4odoC-3q1oA:
16.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ODR_B_FK5B201_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD,
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1A CHIMERA)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 11 LEU A 298
LEU A 291
LEU A 195
ILE A 191
PHE A  49
 None
 0.98A 4odrA-3q1oA:
undetectable
4odrB-3q1oA:
undetectable		 4odrA-3q1oA:
14.19
4odrB-3q1oA:
14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OGU_A_210A405_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 9 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.24A 4oguA-3q1oA:
30.9		 4oguA-3q1oA:
27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OGU_A_210A405_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 LEU A  89
ASP A  92
ASP A  98
ARG A 103
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.47A 4oguA-3q1oA:
30.9		 4oguA-3q1oA:
27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P0V_A_ZOLA401_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 9 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.48A 4p0vA-3q1oA:
31.4		 4p0vA-3q1oA:
26.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P0W_A_ZOLA501_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 11 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.53A 4p0wA-3q1oA:
31.4		 4p0wA-3q1oA:
26.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q23_A_RISA901_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.20A 4q23A-3q1oA:
31.0		 4q23A-3q1oA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q23_A_RISA901_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		9 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.49A 4q23A-3q1oA:
31.0		 4q23A-3q1oA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RXD_A_RISA1404_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.22A 4rxdA-3q1oA:
29.4		 4rxdA-3q1oA:
27.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RXD_A_RISA1404_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.50A 4rxdA-3q1oA:
29.4		 4rxdA-3q1oA:
27.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RXD_B_RISB1504_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.22A 4rxdB-3q1oA:
29.9		 4rxdB-3q1oA:
27.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RXD_B_RISB1504_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.49A 4rxdB-3q1oA:
29.9		 4rxdB-3q1oA:
27.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RXD_C_RISC1600_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.23A 4rxdC-3q1oA:
29.9		 4rxdC-3q1oA:
27.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RXD_C_RISC1600_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 10 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.49A 4rxdC-3q1oA:
29.9		 4rxdC-3q1oA:
27.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UMJ_A_BFQA1297_1
(GERANYLTRANSTRANSFER
ASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		7 / 8 SER A  88
LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
 DMA  A 501 (-3.4A)
DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
 0.69A 4umjA-3q1oA:
29.3		 4umjA-3q1oA:
35.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UMJ_A_BFQA1297_1
(GERANYLTRANSTRANSFER
ASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		7 / 8 SER A  88
LEU A  89
ASP A  92
ASP A  98
ARG A 103
MET A 159
LYS A 186
 DMA  A 501 (-3.4A)
DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 (-3.1A)
 0.75A 4umjA-3q1oA:
29.3		 4umjA-3q1oA:
35.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UMJ_B_BFQB1294_1
(GERANYLTRANSTRANSFER
ASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		8 / 9 SER A  88
LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
 DMA  A 501 (-3.4A)
DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
 0.51A 4umjB-3q1oA:
29.7		 4umjB-3q1oA:
35.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UMJ_B_BFQB1294_1
(GERANYLTRANSTRANSFER
ASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		8 / 9 SER A  88
LEU A  89
ASP A  92
ASP A  98
ARG A 103
MET A 159
LYS A 186
THR A 187
 DMA  A 501 (-3.4A)
DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
 0.71A 4umjB-3q1oA:
29.7		 4umjB-3q1oA:
35.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZBQ_A_ACTA605_0
(SERUM ALBUMIN)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 6 HIS A  85
GLY A  46
GLU A  82
ARG A  48
 DMA  A 500 (-3.7A)
DMA  A 500 (-3.4A)
DMA  A 500 ( 4.6A)
None
 0.94A 4zbqA-3q1oA:
2.1		 4zbqA-3q1oA:
19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CG5_A_RISA400_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 12 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.19A 5cg5A-3q1oA:
30.8		 5cg5A-3q1oA:
25.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CG5_A_RISA400_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 12 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.48A 5cg5A-3q1oA:
30.8		 5cg5A-3q1oA:
25.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CG6_A_RISA404_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 12 ASP A  98
ARG A 103
GLN A 225
ASP A 228
LYS A 242
 MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 1.20A 5cg6A-3q1oA:
31.6		 5cg6A-3q1oA:
25.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CG6_A_RISA404_1
(FARNESYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		10 / 12 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
THR A 187
GLN A 225
ASP A 228
LYS A 242
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 500 (-3.4A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
DMA  A 501 (-2.7A)
 0.46A 5cg6A-3q1oA:
31.6		 5cg6A-3q1oA:
25.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ERO_A_210A804_1
(FUSICOCCADIENE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		7 / 9 LEU A  89
ASP A  92
ASP A  98
ARG A 103
LYS A 186
GLN A 225
ASP A 228
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.1A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
 0.69A 5eroA-3q1oA:
24.3		 5eroA-3q1oA:
26.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ERO_B_210B804_1
(FUSICOCCADIENE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		7 / 9 ASP A  92
ASP A  98
ARG A 103
LYS A 186
GLN A 225
ASP A 228
ASP A 229
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.1A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
None
 0.76A 5eroB-3q1oA:
24.5		 5eroB-3q1oA:
26.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ERO_B_210B804_1
(FUSICOCCADIENE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 9 ASP A  92
ASP A  98
LYS A 186
GLN A 225
ASP A 228
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.1A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
 1.50A 5eroB-3q1oA:
24.5		 5eroB-3q1oA:
26.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ERO_C_210C804_1
(FUSICOCCADIENE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		7 / 10 ASP A  92
ASP A  93
ASP A  98
ARG A 103
GLN A 225
ASP A 228
ASP A 229
 MG  A 400 ( 2.8A)
None
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
None
 0.75A 5eroC-3q1oA:
24.6		 5eroC-3q1oA:
26.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ERO_C_210C804_1
(FUSICOCCADIENE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		7 / 10 ASP A  92
ASP A  93
ASP A  98
LYS A 186
GLN A 225
ASP A 228
ASP A 229
 MG  A 400 ( 2.8A)
None
MG  A 400 ( 3.2A)
DMA  A 501 (-3.1A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
None
 0.61A 5eroC-3q1oA:
24.6		 5eroC-3q1oA:
26.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ERO_C_210C804_1
(FUSICOCCADIENE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  92
ASP A  98
ARG A 103
ASP A 229
LYS A 242
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
None
DMA  A 501 (-2.7A)
 1.29A 5eroC-3q1oA:
24.6		 5eroC-3q1oA:
26.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ERO_C_210C804_1
(FUSICOCCADIENE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 10 ASP A  92
ASP A  98
LYS A 186
GLN A 225
ASP A 228
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.1A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
 1.47A 5eroC-3q1oA:
24.6		 5eroC-3q1oA:
26.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ERO_C_210C804_1
(FUSICOCCADIENE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		6 / 10 ASP A  98
ASP A  93
ARG A 103
GLN A 225
ASP A 228
ASP A 229
 MG  A 400 ( 3.2A)
None
DMA  A 501 (-3.0A)
DMA  A 501 ( 3.8A)
DMA  A 501 ( 3.5A)
None
 1.39A 5eroC-3q1oA:
24.6		 5eroC-3q1oA:
26.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5H4D_A_BBIA403_1
(NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 6 PHE A 253
GLU A 184
GLU A 272
VAL A 273
 None
 1.28A 5h4dA-3q1oA:
undetectable		 5h4dA-3q1oA:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IEN_B_VDYB201_2
(CDL2.2)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 12 LEU A 298
LEU A 277
ILE A 191
ALA A  56
LEU A  53
 None
 1.23A 5ienB-3q1oA:
undetectable		 5ienB-3q1oA:
16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_A_ZOLA401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		6 / 7 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
GLN A 225
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 501 ( 3.8A)
 1.00A 6g31A-3q1oA:
23.2		 6g31A-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_B_ZOLB401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 6 ASP A  92
ASP A  98
ARG A 103
GLN A 163
GLN A 225
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 ( 3.8A)
 0.81A 6g31B-3q1oA:
23.3		 6g31B-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_C_ZOLC401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 5 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
 1.12A 6g31C-3q1oA:
23.4		 6g31C-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_D_ZOLD401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		6 / 7 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
GLN A 225
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 ( 3.8A)
 0.63A 6g31D-3q1oA:
22.4		 6g31D-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_E_ZOLE401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 4 LEU A  89
ASP A  92
ASP A  98
ARG A 103
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
 0.47A 6g31E-3q1oA:
17.4		 6g31E-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_F_ZOLF401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 5 ASP A  92
ASP A  98
ARG A 103
GLN A 163
GLN A 225
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 ( 3.8A)
 0.69A 6g31F-3q1oA:
23.4		 6g31F-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_G_ZOLG401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		6 / 7 ASP A  92
ASP A  98
ARG A 103
GLN A 163
LYS A 186
GLN A 225
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 (-3.1A)
DMA  A 501 ( 3.8A)
 0.69A 6g31G-3q1oA:
22.0		 6g31G-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_H_ZOLH401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 5 ASP A  92
ASP A  98
GLN A 163
GLN A 225
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.6A)
DMA  A 501 ( 3.8A)
 0.62A 6g31H-3q1oA:
22.1		 6g31H-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_I_ZOLI401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 4 ASP A  92
ASP A  98
LYS A 186
GLN A 225
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.1A)
DMA  A 501 ( 3.8A)
 0.83A 6g31I-3q1oA:
22.9		 6g31I-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_J_ZOLJ401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 6 LEU A  89
ASP A  92
ASP A  98
ARG A 103
GLN A 163
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
 0.96A 6g31J-3q1oA:
23.4		 6g31J-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_J_ZOLJ401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 6 LEU A  89
ASP A  92
ASP A  98
GLN A 163
GLN A 225
 DMA  A 501 ( 4.8A)
MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.6A)
DMA  A 501 ( 3.8A)
 0.65A 6g31J-3q1oA:
23.4		 6g31J-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_K_ZOLK401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 4 ASP A  92
ASP A  98
ARG A 103
GLN A 163
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
 0.62A 6g31K-3q1oA:
21.6		 6g31K-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_L_ZOLL401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		5 / 6 ASP A  92
ASP A  98
ARG A 103
GLN A 163
GLN A 225
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.0A)
DMA  A 501 (-3.6A)
DMA  A 501 ( 3.8A)
 0.87A 6g31L-3q1oA:
23.1		 6g31L-3q1oA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_L_ZOLL401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)		 3q1o GERANYLTRANSTRANSFER
ASE (ISPA)
(Helicobacter
pylori) 		4 / 6 ASP A  92
ASP A  98
GLN A 163
LYS A 250
 MG  A 400 ( 2.8A)
MG  A 400 ( 3.2A)
DMA  A 501 (-3.6A)
None
 1.50A 6g31L-3q1oA:
23.1		 6g31L-3q1oA:
14.29